FDA review News

Latest Articles

• Novel Weight Loss Pill Orforglipron Outperforms Oral Semaglutide in Blood Sugar Control and Weight Loss

  Published: Feb 26, 2026

  Section: Health

  A Phase 3 randomized controlled trial published in The Lancet has demonstrated that orforglipron, a new oral GLP-1 receptor agonist, delivers superior reductions in blood sugar and...

• FDA Fast-Tracks Review for Moderna’s mRNA Flu Vaccine Following Major Policy Reversal

  Published: Feb 21, 2026

  Section: Health

  The U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA-based influenza vaccine, mRNA-1010, after previously suggesting the firm needed more da...